Related Experiment Videos
Novel Alzheimer's disease risk genes: exhaustive investigation is paramount
Kristel Sleegers1,2, Christine Van Broeckhoven3,4
1Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, University of Antwerp-CDE, Universiteitsplein 1, 2610, Antwerp, Belgium. kristel.sleegers@uantwerpen.vib.be.
Acta Neuropathologica
|July 14, 2019
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genomics link obesity and type 2 diabetes to Alzheimer's disease to unveil novel biological insights.
medRxiv : the preprint server for health sciences·2026
Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy pathology.
Neurobiology of aging·2026
Machine learning in Alzheimer's disease genetics.
Nature communications·2025
Alzheimer's disease and its co-pathologies: Implications for hippocampal degeneration, cognitive decline, and the role of APOE ε4.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Peripheral TDP-43 pathology in amyotrophic lateral sclerosis: toward a systemic proteinopathy.
Acta neuropathologica·2026
Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer's vulnerability.
Acta neuropathologica·2026
Cross-Ethnic Replication of Intersectin-1 as a Parkinson's Disease Susceptibility Gene in a Large Chinese Cohort.
Movement disorders : official journal of the Movement Disorder Society·2026
Chromosomal abnormalities in isolated persistent left superior vena cava: A systematic review and meta-analysis.
Turkish journal of obstetrics and gynecology·2026
The rate and spectrum of germline mutations in chicken from a commercial pedigree line.
Genetics, selection, evolution : GSE·2026
Delving into the clinical and genetic spectrum of NLSDM: A case study.
Journal of neuromuscular diseases·2026
Mutation Spectrum and Novel Rare Variants in a Han Chinese Hearing Loss Cohort Using a Tiered Sequencing Strategy.
Molecular genetics & genomic medicine·2026